Elekta's annual report for 2019/20 available

STOCKHOLM, July 10, 2020 – Elekta’s (EKTA-B.ST) annual report for 2019/20 can now be downloaded from the investor section on Elekta’s website, www.elekta.com/investors, and is also enclosed with this press release. The annual report also contains Elekta's sustainability report, based on GRI Standards.

Two new members of Elekta’s Executive Management are presented in the annual report: Andrew Wilson, President Oncology Informatics Solutions and Larry Biscotti, Executive Vice President, Region North and Central America. Both have held their respective positions on an interim basis for some time. As the positions have now become permanent, they are also part of Elekta's Executive Management.

In the annual report, the Parent Company's financial statements have been adjusted, compared with Elekta's year-end report, as a result of a write-down amounting to SEK 107 million for the value of the financial investment in ViewRay, Inc. (Nasdaq: VRAY). This adjustment does not affect the Group's financial statements.

# # #

For further information, please contact:
Cecilia Ketels, Head of Investor Relations
Tel: +46 76 611 76 25, e-mail: cecilia.ketels@elekta.com
Time zone: CET: Central European Time

Mattias Thorsson, Head of Corporate Communications and Public Affairs
Tel: +46 70 865 8012, e-mail: Mattias.Thorsson@elekta.com  
Time zone: CET: Central European Time

This is information that Elekta AB is obliged to make public pursuant to the Securities Markets Act. The information was submitted for publication at 11:00 CET on July 10, 2020. (REGMAR)
 

About Elekta
For almost five decades, Elekta has been a leader in precision radiation medicine. Our more than 4,000 employees worldwide are committed to ensuring everyone in the world with cancer has access to – and benefits from – more precise, personalized radiotherapy treatments. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm Exchange. Visit elekta.com or follow @Elekta on Twitter.